Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

News

  1. Home>
  2. News>
  3. News

India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield

  • Post published:November 16, 2026
  • Post category:News

India has approved its first midazolam nasal spray. CDSCO granted New Drug Permission to Biodeal Pharmaceuticals for an indigenously developed Midazolam Nasal Spray 1.25% w/v on 5 May 2025 —…

Continue Reading India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield

NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027

  • Post published:November 14, 2026
  • Post category:News

India's medical-device price cap on orthopaedic knee implants will stay in force past its scheduled expiry. The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has extended the…

Continue Reading NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027

India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

  • Post published:November 12, 2026
  • Post category:News

India regulates plant-based medicines through three legally separate doors, and only one of them is treated like a modern drug. That door is the phytopharmaceutical category — a purified, standardised…

Continue Reading India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Only 5 of 16 States Onboard CDSCO SUGAM Labs Quality Portal

  • Post published:November 10, 2026
  • Post category:News

Just 5 of the 16 states and union territories that applied to be onboarded on the Central Drugs Standard Control Organisation (CDSCO) SUGAM Labs portal have actually completed the process.…

Continue Reading Only 5 of 16 States Onboard CDSCO SUGAM Labs Quality Portal
  • 1
  • 2
  • 3
  • 4
  • …
  • 20
  • Go to the next page

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
    November 16, 2026/
    0 Comments
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
    November 15, 2026/
    0 Comments
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
    November 14, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • India’s First Midazolam Nasal Spray: CDSCO Nod, 5-Year Shield
  • How to Challenge Medicine Overcharging in India: DPCO Display Rules
  • NPPA Extends Knee Implant Price Cap: What Buyers Must Check in 2027
  • How to Read a CDSCO Clinical Trial Approval: A 2026 Buyer’s Guide
  • India’s Phytopharmaceutical Rules: 4-Marker Standard for Herbals

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve